Tseng Daniel S, Li Dan, Cholleti Sri M, Wei Julia C, Jodesty Yves, Pham Hung-Viet
Department of Adult and Family Medicine, Campbell Medical Offices, CA.
Department of Gastroenterology, Santa Clara Medical Center, CA.
Perm J. 2019;23. doi: 10.7812/TPP/18-195.
A large number of patients with iron deficiency anemia have no known cause of their anemia despite a full evaluation. Optimal management and follow-up for this issue is unclear. Results of previous studies have implicated Helicobacter pylori infection as a potential cause of iron deficiency anemia.
To investigate whether H pylori infection could be a cause of unexplained iron deficiency anemia.
All adult patients with both unexplained iron deficiency anemia and H pylori infection diagnosed between January 1, 2008 and April 30, 2015 were identified from Kaiser Permanente Northern California's electronic medical records database and were followed-up for up to 2 years. We employed bivariate statistics to analyze demographic and clinical characteristics between H pylori treatment groups (treated and untreated). Multivariable logistic regression was used to assess the odds of continued presence of anemia at follow-up.
Of 508 subjects who fit our inclusion criteria, 408 subjects were treated for H pylori. The median initial level of hemoglobin was 10.5 g/dL and ferritin was 7.0 ng/mL. No difference existed in the continued presence of iron deficiency anemia at follow-up between those treated for H pylori and those not treated (24.3% vs 26.5%, p = 0.71). Both groups had improved levels of hemoglobin (25.4% mean increase in treated vs 27.5% mean increase in untreated) at follow-up.
In contrast to the findings of previous studies, we found no evidence that H pylori is involved in causing iron deficiency anemia. Iron deficiency anemia resolved in most subjects regardless of H pylori treatment status.
尽管进行了全面评估,但大量缺铁性贫血患者的贫血病因仍不明。对此问题的最佳管理和随访尚不明确。既往研究结果提示幽门螺杆菌感染可能是缺铁性贫血的一个病因。
调查幽门螺杆菌感染是否可能是不明原因缺铁性贫血的病因。
从北加利福尼亚凯撒医疗集团的电子病历数据库中识别出2008年1月1日至2015年4月30日期间诊断为不明原因缺铁性贫血且感染幽门螺杆菌的所有成年患者,并对其进行长达2年的随访。我们采用双变量统计分析幽门螺杆菌治疗组(治疗组和未治疗组)之间的人口统计学和临床特征。多变量逻辑回归用于评估随访时贫血持续存在的几率。
在符合我们纳入标准的508名受试者中,408名受试者接受了幽门螺杆菌治疗。血红蛋白初始水平中位数为10.5g/dL,铁蛋白为7.0ng/mL。接受幽门螺杆菌治疗的患者与未接受治疗的患者在随访时缺铁性贫血持续存在情况无差异(24.3%对26.5%,p = 0.71)。两组在随访时血红蛋白水平均有所改善(治疗组平均升高25.4%,未治疗组平均升高27.5%)。
与既往研究结果相反,我们没有发现证据表明幽门螺杆菌参与导致缺铁性贫血。无论幽门螺杆菌治疗状态如何,大多数受试者的缺铁性贫血都得到了缓解。